Role of Interleukin 1 in Atopic Dermatitis

Dermatologic Clinics

Volumn 31, Issue 3, 2013, Pages 437-444

  Abramovits, William ^a,b,c   Rivas Bejarano, Joaquin J ^d,e   Valdecantos, Wendell C ^d  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Dermatology Treatment and Research Center   (United States)

^d ABBVIE INC   (United States)

^e LONE STAR COLLEGE   (United States)

Author keywords

Atopic dermatitis; Cytokines; Eczema; Inflammasome; Interleukin 1; Mononuclear cells; Neutrophils; T cells

Indexed keywords

CRYOPYRIN; CYTOKINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 33; INTERLEUKIN 37; INTERLEUKIN 38; MONOCYTE CHEMOTACTIC PROTEIN 1; PATTERN RECOGNITION RECEPTOR; TUMOR NECROSIS FACTOR DECOY RECEPTOR; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ATOPIC DERMATITIS; BINDING AFFINITY; CELL DIFFERENTIATION; CYTOKINE RELEASE; DISEASE SEVERITY; ENZYME ACTIVATION; HUMAN; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; TH17 CELL; TH2 CELL; TRANSCRIPTION REGULATION; UPREGULATION;

ATOPIC DERMATITIS; CYTOKINES; ECZEMA; INFLAMMASOME; INTERLEUKIN 1; MONONUCLEAR CELLS; NEUTROPHILS; T CELLS;

DERMATITIS, ATOPIC; HUMANS; INTERLEUKIN-1;

EID: 84879855806     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2013.04.008     Document Type: Review

References (26)

1. Krause K., Metz M., Makris M., et al. The role of interleukin-1 in allergy-related disorders. Curr Opin Allergy Clin Immunol 2012, 12(5):477-484.
2. O'Neill L.A. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 2008, 226:10-18.
3. Contassot E., Beer H.D., French L.E. Interleukin-1, inflammasomes, autoinflammation and the skin. Swiss Med Wkly 2012, 142:w13590.
4. Jensen L.E. Targeting the IL-1 family members in skin inflammation. Curr Opin Investig Drugs 2010, 11(11):1211-1220.
5. Terui T., Hirao T., Sato Y., et al. An increased ratio of interleukin-1 receptor antagonist to interleukin-1 alpha in inflammatory skin diseases. Exp Dermatol 1998, 7(6):327-334.
6. Renne J., Schäfer V., Werfel T., et al. Interleukin-1 from epithelial cells fosters T cell-dependent skin inflammation. Br J Dermatol 2010, 162(6):1198-1205.
7. Dinarello C.A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011, 117(14):3720-3732.
8. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009, 27:519-550.
9. Weber A., Wasiliew P., Kracht M. Interleukin-1 (IL-1) pathway. Sci Signal 2010, 3:cm1.
10. Huising M.O., Stet R.J., Savelkoul H.F., et al. The Molecular evolution of the IL-1 family of cytokines. Dev Comp Immunol 2004, 28(5):395-413.
11. Carriere V., Roussel L., Ortega N., et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor invivo. Proc Natl Acad Sci U S A 2007, 104(1):282-287.
12. Werman A., Werman-Venkert R., White R., et al. The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc Natl Acad Sci U S A 2004, 101(8):2434-2439.
13. Sharma S., Kulak N., Nold M.F., et al. The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. JImmunol 2008, 180(8):5477-5482.
14. Nold M.F., Nold-Petry C.A., Zepp J.A., et al. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 2010, 11(11):1014-1022.
15. Di Paolo N.C., Shayakhmetov D.M. Interleukin-1 receptor 2 keeps the lid on interleukin-1α. Immunity 2013, 38(2):203-205.
16. Banerjee M., Saxena M. Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes. Clin Chim Acta 2012, 413(15-16):1163-1170.
17. Goldbach-Mansky R. Blocking IL-1 in rheumatic diseases. Ann N Y Acad Sci 2009, 1182:111-123.
18. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
19. Agata H., Kondo N., Fukutomi O., et al. Interleukin-2 production of lymphocytes in food sensitive atopic dermatitis. Arch Dis Child 1992, 67(3):280-284.
20. Arend W.P., Malyak M., Guthridge C.J., et al. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998, 16:27-55.
21. Watanabe H., Gaide O., Petrilli V., et al. Activation of the IL-1 beta processing inflammasome is involved in contact hypersensibility. JInvest Dermatol 2007, 127:1956-1963.
22. Greally P., Hussain N.J., Price J.F., et al. IL-1 alpha and soluble IL-2 receptors in atopic dermatitis. Arch Dis Child 1992, 67:1413.
23. Blumberg H., Hugen D., Tomeblood E., et al. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. JExp Med 2007, 204(11):2603-2626.
24. Rania M., Hay A., Hoha F., et al. The role of IL-1 beta and IL-33 in atopic dermatitis. Our Dermatol Online 2013, 4(1):11-14.
25. Ferda C., et al. IL-33: a novel danger signal system in atopic dermatitis. JInvest Dermatol 2012, 132(5):1326-1329.
26. Nutan F., Kanwar A.J., Parsad D. The effect of topically applied corticosteroids on interleukin 1beta levels in patients with atopic dermatitis. JEur Acad Dermatol Venereol 2012, 26(8):1020-1022.